Semler Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 68 to 82.
Looking For The Best Stocks To Buy And Watch? Start Here
This proprietary rating measures technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against other publicly traded companies.
History reveals that the market's biggest winners often have an RS Rating of at least 80 in the early stages of their moves.
Is Semler Scientific Stock A Buy?
Semler Scientific stock recently reclaimed its 200-day moving average and is not in a proper buy range. Look for the medical stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
The medical device and software company posted 0% earnings growth in the latest quarterly report, while sales growth came in at -44%.
Semler Scientific stock holds the No. 44 rank among its peers in the Medical-Products industry group. Insulet, Boston Scientific and ResMed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
